As America’s biopharmaceutical companies work around the clock to combat COVID-19, another virus with deadly consequences is right around the corner. The COVID-19 pandemic has led to more than 7.5 million infections and tragically more than 210,000 deaths. The influenza virus, more commonly known as the flu, is starting to circulate in the U.S. This year, already-strained health systems across the U.S. are preparing for a double whammy: flu season compounded by the ongoing COVID-19 pandemic.
